‘We are at a crossroads’: Prince Harry and Meghan Markle issue new video message Political Novice Levi Strauss Heir Defeats ...

Atrial fibrillation, or AFib is the most common type of heart arrhythmia. A new type of procedure is helping get hearts back on beat.

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

More than six million Americans experience atrial fibrillation, or Afib, each year. Penn Stare Health Heart and Vascular is now offering a new, very focused and safe approach to treating Afib, ...

After two years of treatment to get Afib under control, Thosani enrolled in the REACT-AF study, and says he has been off his ...

Johnson & Johnson MedTech has received the US Food and Drug Administration (FDA) approval for its VARIPULSE Platform to treat ...

Irvine: Johnson & Johnson MedTech has announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform ...

REDDING, Calif. — The staff at Shasta Regional Medical Center (SRMC) is celebrating their 100th Watchman heart implant ...

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing ...

Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.

Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...